3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole has been researched along with levodopa in 1 studies
Studies (3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole) | Trials (3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole) | Recent Studies (post-2010) (3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
---|---|---|---|---|---|
18 | 1 | 0 | 17,774 | 1,900 | 4,946 |
Protein | Taxonomy | 3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole (IC50) | levodopa (IC50) |
---|---|---|---|
integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adler, CH; Bohmaker, K; Friedhoff, AJ; Goldstein, M; Helmer-Matyjek, E; Meller, E | 1 |
1 other study(ies) available for 3-(4-(4-phenyl-1,2,3,6-tetrahydropyridyl-1)-butyl)indole and levodopa
Article | Year |
---|---|
Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists.
Topics: 4-Butyrolactone; Animals; Apomorphine; Corpus Striatum; Indoles; Levodopa; Male; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1986 |